Distribution of HPV genotypes in cervical cancer in multi-ethnic malaysia

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 2, 2014, Pages 651-656

  Raub, Sayyidi Hamzi Abdul ^a   Isa, Nurismah Md ^a   Zailani, Hatta Ahmad ^a   Omar, Baharudin ^a   Abdullah, Mohamad Farouk ^b   Amin, Wan Anna Mohd ^b   Noor, Rushdan Md ^b   Ayub, Mukarramah Che ^c   Abidin, Zainal ^c   Kassim, Fauziah ^d   Vicknesh, Visvalingam ^d   Zakaria, Zubaidah ^e   Kamaluddin, Muhammad Amir ^e   Tan, Geok Chin ^a   Husain, Sharifah Noor Akmal Syed ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b Hospital Sultanah Bahiyah   (Malaysia)

^c Hospital Raja Perempuan Zainab II   (Malaysia)

^d HOSPITAL KUALA LUMPUR   (Malaysia)

^e INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

Author keywords

Cervical cancer; Distribution of HPV; HPV genotyping; Human papillomavirus; Malaysia

Indexed keywords

VIRUS DNA;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CLASSIFICATION; ETHNIC GROUP; ETHNOLOGY; FEMALE; FOLLOW UP; GENETICS; GENOTYPE; HUMAN; MALAYSIA; MIDDLE AGED; MULTICENTER STUDY; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SQUAMOUS CELL CARCINOMA; STATISTICS; UTERINE CERVIX TUMOR; VIROLOGY;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALAYSIA; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84894683890     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.2.651     Document Type: Article

References (29)

1. Bachtiary B, Obermair A, Dreier A, et al (2002). Impact of multiple infection response to treatment and survival in patients receiving radical radiotherapy for cervical cancer. Int J Cancer, 102, 237-43.
2. Bao YP, Li N, Smith JS, et al (2008). Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gyn Cancer, 18, 71-9.
3. Capra G, Giovannelli L, Bellavia C, et al (2008). HPV genotype prevalence in cytologically abnormal cervical samples from women living in south Italy. Virus Res, 113, 195-200.
4. Castellsague X, Diaz M, de Sanjose S, et al (2006). International agency for research on cancer multicenter cervical cancer study group. 2006. Worldwide human papillomavirus etiology of cervical ADC and its cofactors: implications for screening and prevention. J Natl Cancer Inst, 98, 303-15.
5. Clifford G, Franceschi S, Diaz M, et al (2006). Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine, 24, 26-34.
6. Clifford GM, Gallus S, Herrero R, et al (2005). Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet, 366, 991-8.
7. Clifford GM, Rana RK, Franceschi S, et al (2005). Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev, 14, 1157-64.
8. Clifford GM, Smith JS, Plummer M, et al (2003). Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer, 88, 63-73.
9. Conrad-Stoppler MC, Chin K, Stoppler H, et al (1996). Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol, 70, 6987-93.
10. de Sanjose S, Quint WG, Alemany L, et al (2010). Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol, 11, 1048-56.
11. Domingo EJ, Noviani R, Noor MRM, et al (2008). Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam. Vaccine, 26, 71-9.
12. Ferlay J, Bray F, Pisani P, et al (2004). GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide, IARC cancer base no. 5. Version 2.0. Lyon: IARC Press 2004.
13. Ferlay J, Shin HR, Bray F, et al (2012). GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10. Lyon, France: International Agency for Research on Cancer.
14. Giannoudis A, Herrington CS (2001). Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol, 193, 295-302.
15. Harper DM, Franco EL, Wheeler C, et al (2004). Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomized controlled trial. Lancet, 364, 1757-65.
16. Liaw KL, Hsing AW, Schiffman MH, et al (1997). Human papillomavirus types 52 and 58 are prevalent in cervical cancer from Chinese women. Int J Cancer, 73, 775-6.
17. Magnusson PKE, Lichtenstein P, Gyllenstein UB (2000). Heritability of cervical tumors. Int J Cancer, 88, 698-701.
18. Munoz N, Bosch FX, de Sanjose S, et al (2003). International agency for research on cancer multicenter study group. epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348, 518-27.
19. Schellekens MC, Dijkman A, Aziz MF, et al (2004). Prevalence of single and multiple HPV types in cervical carcinomas in Jakarta, Indonesia. Gynecol Oncol, 93, 49-53.
20. Schiffman M, Castle PE (2005). The promise of global cervical-cancer prevention. N Engl J Med, 353, 2101-4.
21. Schiffman M, Clifford G, Buonaguro FM (2009). Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infectious Agents and Cancer, 4, 8.
22. Settheetham-Ishida W, Kanjanavirojkul N, Kularbkaew C, et al (2005). Human papillomavirus genotypes and the p53 codon 72 polymorphism in cervical cancer of Northeastern Thailand. Microbiol and Immunol, 49, 417-21.
23. Sharifah E, Sharifah NA, Sayyidi Hamzi AR, et al (2010). Prevalence of human papillomavirus genotypes in preinvasive and invasive cervical cancer-a UKM study. Med & Health, 5, 66-76.
24. Sharifah NA, Seeni A, Nurismah MI, et al (2009). Prevalence of human papillomavirus in abnormal cervical smears in Malaysian patients. Asian Pac J Cancer Prev, 10, 303-6.
25. Smith SJ, Lindsay L, Hoots B, et al (2007). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer, 121, 621-32.
26. Veress G, Szarka K, Dong XP, et al (1999). Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. J Gen Virol, 80, 1043-53.
27. Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9.
28. Wheeler CM, Hunt WC, Schiffman M, et al (2006). Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J Infect Dis, 194, 1291-9.
29. Zainal Ariffin O, Nor Saleha IT (2011). National Cancer Registry Report 2007. Ministry of Health, Malaysia.